nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel loss-of-function heterozygous BRCA2 c.8946_8947delAG mutation found in a Chinese woman with family history of breast cancer
|
Ma, Jing |
|
2017 |
143 |
4 |
p. 631-637 |
artikel |
2 |
A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors
|
Alifieris, Constantinos E. |
|
2017 |
143 |
4 |
p. 717-725 |
artikel |
3 |
CCAT1: an oncogenic long noncoding RNA in human cancers
|
Guo, Xiaoqiang |
|
2016 |
143 |
4 |
p. 555-562 |
artikel |
4 |
Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization
|
Mischinger, Johannes |
|
2016 |
143 |
4 |
p. 677-685 |
artikel |
5 |
Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer
|
Liang, Weiwei |
|
2016 |
143 |
4 |
p. 601-611 |
artikel |
6 |
Current developments in cancer care: including the patients’ perspective—3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany
|
Ortmann, O. |
|
2016 |
143 |
4 |
p. 673-676 |
artikel |
7 |
Depletion of p42.3 gene inhibits proliferation and invasion in melanoma cells
|
Liu, Hui |
|
2017 |
143 |
4 |
p. 639-648 |
artikel |
8 |
Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients
|
Ofner, Richard |
|
2016 |
143 |
4 |
p. 613-617 |
artikel |
9 |
Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting
|
Atkinson, Thomas M. |
|
2017 |
143 |
4 |
p. 735-743 |
artikel |
10 |
Fingerprint changes among cancer patients treated with paclitaxel
|
Azadeh, Payam |
|
2016 |
143 |
4 |
p. 693-701 |
artikel |
11 |
Identification of a prognostic 5-Gene expression signature for gastric cancer
|
Hou, Jun-Yi |
|
2016 |
143 |
4 |
p. 619-629 |
artikel |
12 |
Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme
|
Wang, Jia-Bin |
|
2017 |
143 |
4 |
p. 661-671 |
artikel |
13 |
Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines
|
Kneissl, Julia |
|
2016 |
143 |
4 |
p. 573-600 |
artikel |
14 |
Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up
|
Lin, Jian-Xian |
|
2017 |
143 |
4 |
p. 727-734 |
artikel |
15 |
Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
|
Imataki, Osamu |
|
2017 |
143 |
4 |
p. 709-715 |
artikel |
16 |
Men and women show similar survival rates after breast cancer
|
Bender, Paulo Franscisco Mascarenhas |
|
2016 |
143 |
4 |
p. 563-571 |
artikel |
17 |
Preoperative characteristics of the P.R.O.S.T.A.T.E. scores: a novel predictive tool for the risk of positive surgical margin after radical prostatectomy
|
Xu, Ben |
|
2016 |
143 |
4 |
p. 687-692 |
artikel |
18 |
Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up
|
Eigentler, Thomas Kurt |
|
2016 |
143 |
4 |
p. 703-708 |
artikel |
19 |
Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics
|
Klupczynska, Agnieszka |
|
2017 |
143 |
4 |
p. 649-659 |
artikel |